• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,956.00 2,174.70(%)
  • Bluestone Jewel
    872.60 872.60(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,077.80 1,077.80(%)
  • M & M Fin. Serv.
    384.55 412.30(%)
  • Data Pattern
    4,800.00 4,955.00(%)
  • TVS Motor Co.
    3,965.00 3,970.00(%)
  • Cummins India
    5,635.00 6,142.80(%)
  • Bajaj Auto
    11,025.00 11,025.00(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    601.25 617.30(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,730.10 4,730.10(%)
  • Nestle India
    1,509.75 1,509.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivimed Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 26766.0
  • ISIN : INE526G01021
5.11 0 (-0.39%)
  • As on 22 Jul 2026 (EOD)

  • Today’s Low

    5.05

  • Today’s High

    5.34

  • Open

    5.25

  • Perv Close

    5.13

  • 52W Low

    5.02

  • 52W High

    29.40

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    42.37

  • Div & Yield %

    0.00

  • Book Value(₹)

    -18.11

  • Debt-Equity Ratio

    -0.39

  • AGM Date

    22-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    42.37

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    16.58

  • BV (₹)

    -18.10

  • Sales( ₹ in Cr.)

    55.78

  • NP (in Cr.)

    -171.61

  • NP Var(%)

    -445.0

  • Div%

    0.0

  • CPS (₹)

    -18.50

  • EPS (₹)

    -20.70

  • Traded Value (₹ in Lakhs)

    42.62

  • 52 Week High

    29.40

  • 52 Week Low

    5.02

  • Price BSE

    5.0

  • Price NSE

    5.00

  • Market Capital( in Cr.)

    42.62

  • P/C Ratio

    -0.30

  • P/E Ratio

    -0.20

  • Price Vs.BV

    -20.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 103.60 136.80 176.83 218.37 210.05 276.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 103.60 136.80 176.83 218.37 210.05 276.61
Other Income 4.19 9.57 0.24 1.26 6.08 6.54
Stock Adjustments 1.79 18.07 -62.63 -0.49 -4.31 4.87
Total Income 109.58 164.44 114.44 219.14 211.82 288.02
EXPENDITURE :            
Raw Materials 60.12 85.39 206.00 142.92 92.76 155.17
Power and Fuel Cost 3.48 4.87 8.73 7.55 9.02 8.99
Employee Cost 23.04 29.45 29.67 31.68 26.45 31.87
Other Manufacturing Expenses 6.22 10.26 19.42 17.65 18.98 16.08
Selling and Administration Expenses 27.03 25.87 37.65 26.70 30.76 28.89
Miscellaneous Expenses 0.00 32.17 0.63 0.42 -0.07 7.75
Employee Benefit Expenses 23.04 29.45 29.67 31.68 26.45 31.87
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 119.90 188.00 302.10 226.92 177.91 248.74
Operating Profit -10.33 -23.56 -187.67 -7.78 33.91 39.27
Interest 2.54 2.41 35.55 39.71 41.63 43.44
Gross Profit -12.87 -25.97 -223.22 -47.49 -7.72 -4.17
Depreciation 18.63 18.41 106.91 17.45 15.80 16.57
Profit Before Tax -31.50 -44.38 -330.13 -64.94 -23.52 -20.74
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 -2.12 2.82 -0.23 -1.57
Reported Net Profit -31.50 -44.38 -328.01 -67.75 -23.28 -19.17
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -6.87
Adjusted Net Profit -31.50 -44.38 -328.01 -67.75 -23.28 -12.30
Adjustment below Net Profit 0.58 0.48 4.05 0.56 -6.14 -0.50
P & L Balance brought forward -160.33 -116.42 207.54 274.73 304.15 323.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -191.25 -160.33 -116.42 207.54 274.73 304.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -3.80 -5.35 -39.56 -8.17 -2.81 -2.31
Earnings Per Share(Adj)-Unit Curr - - -39.56 -8.17 -2.81 -2.31
Book Value 2.47 6.20 11.50 50.57 58.67 62.22
Book Value(Adj)-Unit Curr - - 11.50 50.57 58.67 62.22

Shareholding Pattern

  • Promoter Group

    7.57%

  • Public Share Holding

    92.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 434,450 0.52 434,450 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,844,330 7.05 5,844,330 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,278,780 7.57 6,278,780 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 96,130 0.12 96,130 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,362,919 1.64 1,362,919 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,459,049 1.76 1,459,049 6
2] Non Institution
Bodies Corporate 5,333,831 6.43 5,333,831 207
Clearing Members 5,585 0.01 5,585 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,017,762 6.05 3,647,922 449
Foreign Non Institution Other 7,766,387 9.37 7,766,387 1
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,336,978 11.26 9,336,978 40
Individuals holding nominal share capital up to Rs. 1 lakh 47,668,921 57.49 47,653,204 46,770
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,050 0.01 5,050 2
Others 41,572 0.05 41,572 1
Sub Total 75,176,086 90.67 73,790,529 47,472
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 82,913,915 100.00 81,528,358 47,492

Company Background

Vivimed Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vivimed Labs Ltd
  • BSE Code : 26766.0
  • ISIN : INE526G01021

  • Incorporation Year

    1988

  • Registered Office

    Plot No 78-A
    Kolhar Industrial Area, Bidar,
    Karnataka-585403

  • Telephone

    91-8482-232045

  • FAX

    91-8482-232436

  • Chairman

    V Manohar Rao

  • Managing Director

  • Company Secretary

    Yugandhar Kopparthi

  • Auditor

    SVRL & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Vivimed Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vivimed Labs. 5.14 107.79 103.60 -0.25 0.00
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 442.21 430.53 19.27 17.61
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77